Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Sep;83(3):381-412.
doi: 10.1016/j.jinf.2021.05.026. Epub 2021 May 28.

Persistence of humoral immune response to SARS-CoV-2 up to 7 months post-infection: Cross-sectional study, South India, 2020-21

Jeromie Wesley Vivian Thangaraj  1 , Muthusamy Santhosh Kumar  1 , Cp Girish Kumar  1 , V Saravana Kumar  1 , Nathella Pavan Kumar  1 , Tarun Bhatnagar  1 , Manickam Ponnaiah  1 , R Sabarinathan  1 , D Sudharani  1 , Arul Nancy  2 , M Jagadeesan  3 , Subash Babu  2 , Manoj Murhekar  4
Affiliations
Comment

Persistence of humoral immune response to SARS-CoV-2 up to 7 months post-infection: Cross-sectional study, South India, 2020-21

Jeromie Wesley Vivian Thangaraj et al. J Infect. 2021 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest NIL

Figures

Fig. 1
Fig. 1
SARS-CoV-2 specific IgG seropositivity (%) with 95% CIs among recovered COVID-19 patients by duration since infection (N = 755).
See this image and copyright information in PMC

Comment in

Comment on

References

    1. Hanrath A.T., Payne B.A.I., Duncan C.J.A. Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection. J Infect. 2021;82(4):e29–e30. doi: 10.1016/j.jinf.2020.12.023. Apr. - DOI - PMC - PubMed
    1. Sette A., Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell. 2021 Feb 18;184(4):861–880. - PMC - PubMed
    1. Wajnberg A., Amanat F., Firpo A., Altman D.R., Bailey M.J., Mansour M., et al. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months. Science. 2020 Dec 4;370(6521):1227–1230. - PMC - PubMed
    1. Long Q.-.X., Liu B.-.Z., Deng H.-.J., Wu G.-.C., Deng K., Chen Y.-.K., et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020;26(6):845–848. Jun. - PubMed
    1. Ripperger T.J., Uhrlaub J.L., Watanabe M., Wong R., Castaneda Y., Pizzato H.A., et al. Orthogonal SARS-CoV-2 serological assays enable surveillance of low-prevalence communities and reveal durable humoral immunity. Immunity. 2020;53(5):925–933. Nov 17e4. - PMC - PubMed

Substances